Daily non-political popular news in brief.
Disparities among patients with extremity soft-tissue sarcomas
01-22-2008 · EurekAlert!A new study reveals significant racial and ethnic differences in the treatment and survival of patients with soft-tissue sarcomas, a rare but dangerous cancer that begins in muscle, fat, blood vessels or other supporting tissue of the body.
Read more »
Keywords: disparities, patients, extremity, soft-tissue, sarcomas, disparity, patient, soft, tissue, sarcoma
« Previous | Next »
Similar news on "Disparities among patients with extremity soft-tissue sarcomas":
- Patients with soft tissue sarcomas should be treated at high volume centers
07-09-2007 · EurekAlert!
Soft tissue sarcomas -- rare tumors of the connective tissue -- should be treated at the few centers which see most cases, in order to give patients the best chance of good outcomes, concludes an analysis of sarcoma management in Florida, published in the Annals of Surgery last month.
Similar news · Read more »
- Co-operation between GSF and clinic improves outlook for sarcoma patients
07-13-2007 · EurekAlert!
Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology in Chicago, the GSF scientist Professor Dr. Rolf D. Issels, presented the results of the first, randomized worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.
Similar news · Read more »
- Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors
01-02-2007 · EurekAlert!
A study in the Jan. 3 issue of the Journal of the National Cancer Institute quantifies the risk of hereditary retinoblastoma survivors developing specific subtypes of soft tissue sarcomas and finds that this risk persists for decades after the original retinoblastoma diagnosis. The findings emphasize the importance of regular medical surveillance for these patients, the authors say.
Similar news · Read more »
- Racial disparity in breast cancer outcome linked to aggressive tumors
10-23-2006 · EurekAlert!
Malignancies of the breast can be more aggressive and associated with poorer outcome in African-Americans than other races, according to a new study. The study reviewed patient data from two different clinical trial protocols -- to control for healthcare access biases -- and found that African-Americans have tumors with poorer prognostic cellular characteristics and more aggressive clinical presentations, pointing to the possibility that racially influenced tumor biology may contribute to observed racial disparities in breast cancer outcome.
Similar news · Read more »
- Pediatric cancer stem cell identified: understanding the origin of ERMS
05-16-2007 · EurekAlert!
As published in the June 1 issue of Genes & Development, Dr. Leonard Zon (Children's Hospital Boston) and colleagues have identified the cancer stem cell for rhabdomyosarcoma, the most common soft-tissue sarcoma of childhood.
Similar news · Read more »
- Genetic analyis for personalizing of treatment of lung and colon cancer, certain sarcomas
03-05-2007 · EurekAlert!
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity. In concrete, the Biotechnology Laboratory team at the University Hospital (University of Navarra), in close collaboration with the Pharmacogenomics laboratory at the Centre for Applied Medical Research of the same university, undertook these analyses predictive of responses to pharmaceutical drugs in patients with cancer of the lung, the colon and certain types of sarcoma.
Similar news · Read more »
- New technology useful for soft-tissue imaging in interventional radiology procedures
05-04-2007 · EurekAlert!
Soft-tissue cross-sectional imaging acquired on a flat panel C-arm fluoroscopic unit located in the interventional radiology area is feasible and useful for interventional radiology procedures, avoiding the necessity of sending patients out to a CT scanner, according to a new study by researchers from the Baptist Cardiac & Vascular Institute in Miami, FL.
Similar news · Read more »
- CTRC enrolls first patients in Novel Phase II study for sarcoma -- Living virus destroys cancer cell
07-24-2007 · EurekAlert!
The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung. The novel anti-cancer therapy, REOLYSIN, is a living virus, not a chemotherapy drug, that is toxic to cancer cells but not harmful to normal cells.
Similar news · Read more »
- Paracetamol, one of most used analgesics, could slow down bone growth
09-03-2007 · EurekAlert!
UGR scientists stress the need for controlling the use of paracetamol, as it has been proved "in vitro" that it slows down bone regeneration. Their work has demonstrated that applying plasma rich in growth factors, from the patients themselves and applied on the bones, accelerates cell growth. Therefore, it could also be used to regenerate wounds or ulcers when applied over soft tissue. Results of this research have been published in prestigious journals such as Bioscience Reports, Oral Diseases and Physiology and Biochemistry among others.
Similar news · Read more »
- Mouse model advances understanding of synovial sarcoma
04-09-2007 · EurekAlert!
A mouse model for synovial sarcoma has enabled scientists to make tremendous progress toward understanding the origin and pathogenesis of this highly aggressive soft-tissue malignancy. The research, published in the April issue of the journal Cancer Cell, published by Cell Press, provides new information about the timing and environment required for initiation and progression of synovial sarcoma. The mouse model is also likely to serve as an invaluable resource for development of successful therapeutic strategies for this often lethal cancer.
Similar news · Read more »
